Table of Contents
- Key Points
- Why This Research Matters
- How the Research Was Conducted
- Key Findings: The State of Weight-Loss Surgery Research
- Critical Research Gaps Identified
- What This Means for Patients
- Study Limitations
- Recommendations for the Future
- Frequently Asked Questions
- Source Information
Key Points
- A review of 114 randomized trials from 1977–2020 found most bariatric surgery research is small, short-term, and repeats similar questions.
- Weight loss was studied in 87% of trials, but quality of life in only one-third and mental health in only 5%.
- Only 15% of trials were multicenter and just 3.5% were international; most studies followed patients for only 1–2 years.
- Roux-en-Y gastric bypass was studied in most trials, though sleeve gastrectomy is now the most commonly performed procedure.
- Experts recommend standardized outcomes, longer follow-up, and international research collaborations to better answer what patients truly care about.
Why This Research Matters
Over the past 50 years, obesity has grown worldwide to what experts describe as "pandemic proportions." This is not just a cosmetic issue — it's a major health crisis linked to diabetes, heart disease, and many other serious conditions.
Weight-loss surgery, formally known as bariatric surgery (BS), has been practiced since the 1950s and has become a common treatment for severe obesity. Today, it is considered the most successful therapeutic option for severe obesity, offering long-term positive effects that go far beyond simply shedding pounds.
Beyond weight reduction, bariatric surgery provides significant benefits for blood glucose control and diabetes risk. This has led to the rise of what doctors call "metabolic surgery" — surgery performed specifically to treat diabetes and metabolic disorders, even in patients who may not meet traditional weight-based criteria for surgery.
A January 2021 survey by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) reported a total of 604,223 yearly primary bariatric procedures worldwide, with sleeve gastrectomy remaining the most commonly performed procedure. Yet despite this massive volume of surgery, no one had ever systematically mapped the randomized controlled trials — the gold standard of medical evidence — in this field.
This matters because understanding what research has been done, what questions remain unanswered, and where efforts are being wasted is essential for improving patient care. This study set out to fill that gap by mapping every RCT conducted in bariatric surgery since the very first one was published in 1977.
How the Research Was Conducted
The researchers performed a systematic review — a rigorous, structured method of searching and analyzing all available scientific literature on a topic. Their goal was twofold: to map all existing randomized controlled trials in bariatric surgery and to identify where research efforts have been duplicated or neglected.
Here's how they did it, step by step:
- Database searches: From January 2020 to December 2020, they systematically searched two major medical databases — Embase and PubMed — covering research from 1977 (when the first bariatric surgery RCT was published) through 2020.
- Search criteria: They used 2015 Medical Subject Headings (MeSH) terms from the US National Library of Medicine, a standardized vocabulary used to index medical research.
- Study selection: They included trials that compared two bariatric surgery techniques against each other, or bariatric surgery against a medical (non-surgical) treatment, in adult patients. There was no restriction on what outcomes the trials measured.
- Independent review: Two reviewers independently checked each study against the eligibility criteria. When they disagreed, a third reviewer helped reach a consensus.
- Data collection: For each trial, they recorded the comparators (what was being compared), interventions, location, journal, year of publication, number of patients, follow-up times, and patient characteristics including average age, weight, body mass index (BMI), percentage of women, percentage with diabetes, and glycated hemoglobin (HbA1c) levels (a measure of blood sugar control over time).
- Outcome classification: They categorized all outcomes into several groups including efficacy, surgery and perioperative period (around the time of surgery), mortality, complications, and tolerance.
The initial electronic search yielded an enormous pool of 53,258 references — 17,655 from PubMed and 35,603 from Embase. After removing 6,682 duplicates, they excluded 45,286 studies based on their titles and another 897 based on their abstracts. Of the 363 studies selected for full-text evaluation, 114 randomized controlled trials met all criteria and were included in the final analysis.
Key Findings: The State of Weight-Loss Surgery Research
The findings paint a revealing picture of seven decades of research — some encouraging, some concerning, and some frankly wasteful.
Which Procedures Were Studied?
The majority of trials — 73.7% — were based on comparison with Roux-en-Y gastric bypass (RYGB), a procedure that creates a small stomach pouch and reroutes the small intestine. This is notable because while RYGB has long been considered the "gold standard" of bariatric surgery, it is no longer the most commonly performed procedure worldwide.
In fact, sleeve gastrectomy (SG) — a procedure that removes about 80% of the stomach to create a sleeve-shaped pouch — is now the most commonly performed bariatric procedure according to the latest data, yet it has been far less studied. This gap between what surgeons actually do and what researchers actually study is a significant finding of this review.
When and Where Were the Trials Conducted?
- 74.6% of trials were conducted between 2010 and 2020, showing that this field of research is relatively young and expanding rapidly
- 44% of trials were conducted in Europe, making it the most active region for bariatric surgery research
- 15% of trials were multicenter (involving multiple hospitals or clinics)
- Only 3.5% of trials were international — a strikingly low number that suggests a "compartmentalization" of research along national lines
- 88.6% of trials involved current bariatric surgery procedures still in use today
- 71.1% of trials used a surgical comparator (another surgery), rather than comparing surgery to medical treatment
Patient Numbers and Follow-Up: A Major Concern
The median number of patients enrolled in each trial was just 61 patients (interquartile range: 47.3 to 100). This means half of all trials enrolled fewer than 61 people. While this sample size is comparable to other fields of surgical research, it is small compared with medical treatment research.
Follow-up times were equally concerning. Most studies followed patients for only 1 or 2 years:
- 36% of trials had follow-up of 1 year or less
- 22.8% had follow-up between 1 and 2 years
- Only 16% had follow-up between 2 and 3 years
- Just 5 studies (4.4%) had follow-up between 3 and 4 years
- Only 24 studies (21.1%) had follow-up beyond 4 years
This is particularly problematic because obesity is a chronic disease that lasts a lifetime. A 1- or 2-year follow-up is far too short to know whether the benefits of surgery — and its potential complications — hold up over the long term.
Who Was Studied?
The patient populations in these trials were fairly consistent across studies. The median proportion of women was 69.8% (interquartile range: 60–77.8%), reflecting the fact that women are more likely than men to seek bariatric surgery. The median age of participants was 44.4 years (IQR: 37.6–49), and the median BMI was 42.4 kg/m² (IQR: 36.1–45.3), which falls squarely in the severe obesity range.
Notably, 39.5% of the trials were performed specifically in patients with diabetes. In those diabetes-focused studies, a median of 69.8% of participants had diabetes. Interestingly, the researchers point out that the prevalence of diabetes in these trial populations exceeds 70% in some cases — far higher than the actual prevalence of diabetes among bariatric surgery patients in real-world clinical practice, which they note is lower. This disconnect raises questions about whether trial results truly apply to the broader population of patients seeking weight-loss surgery.
When it came to publication impact, only 22.8% of trials were published in journals with an impact factor above 10. (Impact factor is a measure of how often articles in a journal are cited by other researchers; higher numbers generally indicate more influential journals.)
Critical Research Gaps Identified
Perhaps the most important contribution of this study is its detailed analysis of what outcomes researchers chose to measure — and, crucially, what they chose not to measure.
The Most Studied Outcomes
The researchers categorized all outcomes into several groups. Weight loss dominated the field:
- Weight loss was studied in 87% of RCTs — by far the most common outcome
- Obesity-related diseases (such as diabetes, hypertension, and high cholesterol) were studied in 73% of RCTs
- Medical complications were studied in 54% of RCTs
- Surgical complications were studied in 47% of RCTs
- Perioperative time (time around surgery) was measured in 39% of RCTs
- Mortality (death rates) was studied in 33% of RCTs
- Intermediate metabolic markers (measures like blood sugar, insulin resistance, inflammation, gut hormones) were studied in 28% of RCTs
- Tolerance (how well patients tolerated the procedure) was studied in 25% of RCTs
- Eating behavior was studied in just 9% of RCTs
- Health costs were studied in just 9% of RCTs
- Energy expenditure (calories burned) was studied in only 4% of RCTs
Striking Under-Investigated Areas
Some of the most important — and most neglected — areas included:
- Nutritional deficiencies: Studied in only 20% of RCTs, despite the fact that bariatric surgery can dramatically affect the body's ability to absorb essential vitamins and minerals
- Body composition: Studied in only 18% of RCTs — a concern because loss of lean muscle mass after surgery can be pathological (disease-related)
- Mental health: Studied in a mere 5% of RCTs, despite the well-documented appearance of depressive syndromes and addiction issues in some patients after bariatric surgery
- Quality of life: Studied in only one-third of RCTs — particularly striking since the researchers note that quality of life is likely "the most relevant" question to patients themselves
The researchers also noted that while diabetes resolution (curing or improving diabetes) was one of the most studied outcomes, hypertension (high blood pressure) resolution, body composition changes, nutritional deficiency risk, and mental health were all left "under-investigated."
Repeated Questions, Wasted Resources
The study's most damning finding is the degree of research waste. The researchers documented "repetition of small sample size studies, with short follow-up and the same outcomes (weight loss and diabetes resolution)." In other words, researchers have repeatedly asked the same questions in small, underpowered studies rather than building a cumulative, coordinated body of evidence.
The evolution of outcomes over time (shown in the study's Figure 5) demonstrates that the pattern of outcomes studied has been "mainly influenced by the last 10 years" — meaning the recent explosion of research has largely replicated existing work rather than exploring new frontiers.
What This Means for Patients
For patients considering or undergoing bariatric surgery, these findings carry several important implications.
First, the evidence base is narrower than it appears. While hundreds of studies exist, they cluster around a few procedures (particularly RYGB) and a few outcomes (particularly weight loss and diabetes). The evidence base for sleeve gastrectomy — the most commonly performed procedure today — lags behind, which the researchers describe as a "delay or a gap in research concerning SG."
Second, the long-term picture is unclear. Since most trials follow patients for only 1 to 2 years, little is known from controlled trials about what happens 5, 10, or 20 years after surgery. For a chronic disease like obesity, this is a fundamental problem. The researchers note that long-term outcomes such as life expectancy are better addressed by other types of studies, including cohort studies and national administrative databases, which have already provided valuable long-term data.
Third, what matters most to patients may be the least studied. The researchers write: "Assuming that quality of life after BS is the most relevant to patients, we consider that the main question that patients ask themselves when they turn to this surgery has been insufficiently studied." If you are considering bariatric surgery, you likely have questions about what daily life will be like afterward — how your eating habits will change, how your mental health might be affected, whether you'll develop nutritional deficiencies, how your body composition will shift. These are precisely the questions that the research has largely failed to answer.
Fourth, the trial populations may not reflect your reality. With diabetes prevalence in many trials exceeding 70% — far higher than in real-world practice — patients without diabetes may wonder how applicable the results are to them. Similarly, with a median of 69.8% female participants, the evidence is somewhat skewed toward what works in women, though the researchers note these populations are comparable to those generally reported in the bariatric surgery literature.
Study Limitations
The researchers acknowledge several limitations to their own study:
- RCTs only: The review focused exclusively on randomized controlled trials. This provides a "fragmented view" of the scientific literature, since other study types — particularly cohort studies and database analyses — can provide valuable complementary evidence on long-term outcomes such as life expectancy and rare complications.
- Methodological reasoning: The choice to focus on RCTs was deliberate, because evidence from RCTs sits at the top of the "evidence pyramid" — the hierarchy of study designs based on their ability to establish cause and effect. Clinical practice decisions, the researchers note, are ideally based on well-conducted RCTs. But this means some important evidence from other study designs falls outside their analysis.
Recommendations for the Future
The study offers a clear roadmap for improving bariatric surgery research. While these recommendations are aimed primarily at researchers and policymakers, they matter for patients too — because better research translates into better care.
Develop a Core Outcome Set (COS)
The researchers strongly recommend creating a standardized core outcome set (COS) — a minimum list of outcomes that every bariatric surgery trial should measure and report. This would help ensure that studies can be compared, combined, and understood, and that important outcomes (quality of life, mental health, nutritional status) are never overlooked.
They emphasize that this COS should be developed with input from a variety of professionals — surgeons, nutritionists, dietitians, psychiatrists, and psychologists — and, crucially, from patients who have themselves undergone bariatric surgery. They also recommend that the COS be international in scope and regularly updated.
Form Research Consortia
The creation of research consortia — collaborative networks of multiple centers and countries working together — is proposed as a key solution. Consortia could improve the coverage of research questions and enable larger, more definitive trials. Currently, the field is characterized by small, national, single-center trials, with only 15% multicenter and 3.5% international.
Prioritize Long-Term Follow-Up
Given that obesity is a chronic, lifelong disease, the researchers stress the importance of evaluating long-term impacts. Yet less than a quarter of trials followed patients beyond 4 years. They acknowledge that funding long-term studies is a major obstacle, but suggest that researchers should consider other study designs — such as cohort studies and national database analyses — to evaluate long-term effects like life expectancy.
Reconsider Research Questions
Future studies should "reconsider the questions posed," focusing on areas that remain unaddressed rather than repeating existing work. The researchers specifically highlight hypertension resolution, body composition changes, nutritional deficiency risk, and mental health as under-investigated areas that deserve urgent attention.
Use New Research Tools
The study also suggests that new approaches — like phenome-wide association scans (PheWAS), a method that scans the entire range of health outcomes to discover unexpected connections — could allow certain outcomes to emerge "without prior hypothesis." This data-driven approach could uncover effects of bariatric surgery that researchers haven't thought to look for.
Frequently Asked Questions
How many weight-loss surgery clinical trials were reviewed, and over what time period?
Researchers reviewed 114 high-quality randomized controlled trials in bariatric surgery, covering research from the first trial in 1977 through 2020. They screened more than 53,000 scientific references to identify these trials, which compared different surgical techniques or surgery against non-surgical treatment in adult patients.
Why should I be concerned that most weight-loss surgery studies only follow patients for 1 to 2 years?
Obesity is a lifelong chronic disease, so knowing whether surgery’s benefits and risks last is essential. Yet only about 21% of trials followed patients beyond 4 years, and many followed for just 1 or 2 years. This leaves important questions about long-term outcomes, such as life expectancy and late complications, poorly answered.
What weight-loss surgery procedure has been studied the most, and which is most commonly performed now?
Roux-en-Y gastric bypass (RYGB) was studied in about 74% of trials and has long been considered a standard procedure. However, sleeve gastrectomy (SG) is now the most commonly performed bariatric procedure worldwide, yet it has been far less studied. This gap means evidence for the most common surgery lags behind.
Are mental health and quality of life after weight-loss surgery well studied?
No. Mental health was studied in only 5% of trials, and quality of life in only one-third. Researchers noted that quality of life is likely the most relevant question to patients themselves, yet it remains under-investigated. This means limited evidence on depression, addiction issues, and daily life after surgery.
What does it mean that many weight-loss surgery trials had small numbers of patients?
The median number of patients in each trial was just 61. Half of all trials enrolled fewer than 61 people. Such small studies can be less reliable and may miss important differences between procedures. The researchers described repetition of small, short-term studies as a form of research waste.
I do not have diabetes. Will weight-loss surgery research results apply to me?
Maybe not directly. About 39.5% of trials were performed specifically in patients with diabetes, and in those, a median of 69.8% of participants had diabetes. This is much higher than diabetes rates in real-world bariatric surgery patients. So results may be skewed toward people with diabetes.
What do researchers recommend to improve future weight-loss surgery research?
They recommend creating a standardized core outcome set, with input from patients and professionals, so every trial measures important things like quality of life, mental health, and nutrition. They also suggest forming international research consortia, prioritizing long-term follow-up, and focusing on neglected areas like hypertension resolution and nutritional deficiencies.
Should I get a second opinion before bariatric surgery given that research mainly covers short-term weight loss and diabetes, not quality of life or mental health?
Most bariatric surgery trials follow patients for only one to two years, and half enroll fewer than 61 people. They focus heavily on weight loss and diabetes, while mental health is studied in only 5% of trials and quality of life in one-third. The most common procedure today, sleeve gastrectomy, is less studied than gastric bypass. A second opinion can help you weigh these evidence gaps and clarify realistic long-term expectations before deciding. Diagnostic Detectives Network provides independent expert second opinions.
Source Information
Original article title: Paris HEGP Seventy years of bariatric surgery
Authors: Claire Rives-Lange, Nathalie Rassy, Claire Carette, Aurelie Phan, Charles Barsamian, Jeremie Thereaux, David Moszkowicz, Tigran Poghosyan, and Sebastien Czernichow
Journal: Obesity Reviews, 2022;23:e13420 (published by Wiley on behalf of the World Obesity Federation)
DOI: 10.1111/obr.13420
Funding: The study was funded by a grant from the Programme Hospitalier de Recherche Clinique — PHRC 2011 (Ministère de la Santé, AOM11194).
Study affiliation: Assistance Publique—Hôpitaux de Paris (AP-HP), Nutrition Department, European Hospital Georges Pompidou, Paris, France; University of Paris; INSERM; and other French institutions.
Note: This patient-friendly article is based on peer-reviewed research. It has been written to make the findings accessible to a general audience while preserving all key data, statistics, and conclusions from the original scientific publication. Some authors of the original study disclosed consulting fees and other financial relationships with pharmaceutical and medical device companies; these are detailed in the original article's conflict of interest statement.
